Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 226,184,861 papers from all fields of science
Search
Sign In
Create Free Account
prorenoate potassium
Known as:
potassium prorenoate
The potassium salt form of prorenoate, a steroidal aldosterone antagonist with potassium-sparing diuretic activity. Prorenoate antagonizes the…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
3 relations
Broader (1)
Spironolactone
analogs & derivatives
prorenoate
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
1995
1995
Aldosterone (ALDO) increases transmembrane influx of Na+ in vascular smooth muscle (VSM) cells through increased synthesis of Na+ channels
L. Kornel
,
Barbara Smoszna-Konaszewska
Steroids
1995
Corpus ID: 25467757
1989
1989
Studies on spirolactone steroid antagonists in ACTH-induced hypertension in sheep.
A. Reid
,
J. Coghlan
,
C. D. Spence
,
J. Whitworth
,
B. Scoggins
Journal of Steroid Biochemistry
1989
Corpus ID: 13415466
1982
1982
Comparison of prorenoate potassium and spironolactone after repeated doses and steady state plasma levels of active metabolites.
G. Mcinnes
,
J. Shelton
,
I. Harrison
,
R. Perkins
,
R. Palmer
British Journal of Clinical Pharmacology
1982
Corpus ID: 26071952
1 After repeated single daily doses, the aldosterone antagonists prorenoate potassium and spironolactone were compared with…
Expand
1982
1982
Detection and comparative evaluation of aldosterone antagonists in glucocorticoid-treated, adrenalectomized rats.
J. Casals-stenzel
,
M. Buse
,
W. Losert
European Journal of Pharmacology
1982
Corpus ID: 24640258
1982
1982
Effect of aldosterone antagonists on mineralocorticoid synthesis in vitro. Inhibition of aldosterone production by prorenoate-K.
P. Netchitailo
,
P. Netchitailo
,
+17 authors
H. Vaudry
European Journal of Pharmacology
1982
Corpus ID: 4615886
1981
1981
Steady‐state relative potency of aldosterone antagonists: Spironolactone and prorenoate
G. Mcinnes
,
J. Shelton
,
I. Harrison
Clinical pharmacology and therapy
1981
Corpus ID: 22611442
The dose ratio approach was used to define the steady‐state relative potency of the competitive mineralocorticoid antagonists…
Expand
1979
1979
Comparative effects of canrenoate-k and prorenoate-k upon aldosterone biosynthesis in perifused frog interrenal glands
C. Delarue
,
F. Leboulenger
,
+6 authors
H. Vaudry
Steroids
1979
Corpus ID: 10248978
1976
1976
The pharmacodynamics of single doses of prorenoate potasssium and spironolactone in fludrocortisone treated normal subjects.
L. Ramsay
,
J. Shelton
,
M. Tidd
British Journal of Clinical Pharmacology
1976
Corpus ID: 25483846
1 The pharmacodynamic profile of single oral doses of prorenoate potassium (40 mg) and spironolactone (100 mg), as judged by…
Expand
1976
1976
Antagonism of endogenous mineralocorticoids in normal subjects by prorenoate potassium and spironolactone
D. Levine
,
L. Ramsay
,
R. Auty
,
R. Branch
,
M. Tidd
European Journal of Clinical Pharmacology
1976
Corpus ID: 7048159
SummaryThe pharmacological activity of single oral doses of a new aldosterone antagonist, prorenoate potassium, has been compared…
Expand
1975
1975
Relative potency of prorenoate and spironolactone in normal man
L. Ramsay
,
I. Harrison
,
J. Shelton
,
M. Tidd
Clinical pharmacology and therapy
1975
Corpus ID: 22443151
The potency of single doses of a new aldosterone antagonist, prorenoate, in reversing the renal effects of the synthetic…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE